...
首页> 外文期刊>Cogent Medicine >Association of MTHFR 677CT genetic polymorphism with hyperhomocysteinemia in type 2 diabetes patients
【24h】

Association of MTHFR 677CT genetic polymorphism with hyperhomocysteinemia in type 2 diabetes patients

机译:MTHFR 677C> T基因多态性与2型糖尿病患者高同型半胱氨酸血症的关系

获取原文
           

摘要

To explore the association of serum hyperhomocysteinaemia with 677CT polymorphism in MTHFR gene among metformin-treated patients with type 2 diabetes. Serum-homocysteine levels of 227 diabetic subjects were measured before and after the metformin administration were analyzed statistically with respect to their genotype data for MTHFR 677CT polymorphism. CC was the most prevalent genotype at MTHFR 677CT in our sample and associated with the lowest homocysteine level. The patients with TT genotype had significantly elevated homocysteine compared with CC following metformin use (OR_(Baseline)?=?3.434 and 95% CI:0.622–4.127 vs. OR_(Endpoint)?=?4.466 95% CI:3.124–5.53). A distinct statistical association between hyperhomocysteinaemia and the carriage of MTHFR 677CT polymorphism was established among Indian diabetic patients who were treated with metformin. Our study underscores the importance of phamacogenetic analysis in diabetes-related therapeutics.
机译:目的探讨二甲双胍治疗的2型糖尿病患者血清高同型半胱氨酸血症与MTHFR基因677C> T多态性的关系。在服用二甲双胍之前和之后,对227名糖尿病患者的血清同型半胱氨酸水平进行了测量,并对其MTHFR 677C> T多态性的基因型数据进行了统计学分析。 CC是我们样本中MTHFR 677C> T最普遍的基因型,与同型半胱氨酸水平最低相关。与使用二甲双胍后的CC相比,具有TT基因型的患者的同型半胱氨酸水平显着升高(OR_(基线)≤?3.434和95%CI:0.622–4.127,而OR_(终点)≤?4.466 95%CI:3.124–5.53) 。在接受二甲双胍治疗的印度糖尿病患者中,高同型半胱氨酸血症与MTHFR 677C> T多态性的携带之间存在明显的统计学联系。我们的研究强调了在与糖尿病相关的治疗方法中进行基因发生分析的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号